Get started
Author

Oana Cojocarasu

Observed names: Cojocarasu Oana, Cojocarasu, Oana, O. Cojocarasu, O.S. Cojocarasu, Oana COJOCARASU, Oana Zveltlana Cojocarasu, Oana-Zvetlana Cojocarasu
Observed institutions: Centre Hospitalier Universitaire de Besançon, Hôpital Européen Georges-Pompidou, Le Mans Université, Hôpital Nord, Pitié-Salpêtrière Hospital, Centre François Baclesse, Centre Hospitalier du Mans
OpenAlex ID: A5064765271
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial
2021 · Joël Guigay, Anne Aupérin, et al. · The Lancet Oncology · 233
Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study
2019 · Cynthia Reichling, Julien Taieb, et al. · Gut · 122
PDF
Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach
2017 · Michele Boisdron-Celle, Olivier Capitain, et al. · Seminars in Oncology · 80
Complete cerebral response with sunitinib for metastatic renal cell carcinoma
2007 · J. Medioni, O. Cojocarasu, et al. · Annals of Oncology · 76
PDF
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study
2017 · H. Bourgeois, F. Grudé, et al. · Annals of Oncology · 54
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients
2017 · J. Gligorov, B. Ataseven, et al. · European Journal of Cancer · 46
Management of gastric neuro-endocrine tumours in a large French national cohort (GTE)
2017 · Sylvain Manfredi, Thomas Walter, et al. · Endocrine · 29
PDF
EWOC-1: A randomized trial to evaluate the feasibility of three different first-line chemotherapy regimens for vulnerable elderly women with ovarian cancer (OC): A GCIG-ENGOT-GINECO study.
2019 · Claire Falandry, Aude Marie Savoye, et al. · Journal of Clinical Oncology · 26
Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX)
2020 · Yves Rinaldi, Anne-Laure Pointet, et al. · European Journal of Cancer · 19
Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial
2025 · Etienne Brain, Olivier Mir, et al. · The Lancet · 18
Reversible encephalopathy syndrome secondary to sunitinib for metastatic renal cell carcinoma patient
2007 · Jacques Medioni, Oana Cojocarasu, et al. · Targeted Oncology · 16
GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients
2016 · David G. Cox, Elsa Curtit, et al. · Oncotarget · 15
PDF
Building a biopsychosocial model of cancer-related fatigue: the BIOCARE FActory cohort study protocol
2021 · M. Chartogne, A. Leclercq, et al. · BMC Cancer · 14
PDF
Efficacy and safety of FOLFIRINOX in patients with metastatic pancreatic cancer.
2014 · Jean Philippe Metges, Jean François Ramée, et al. · Journal of Clinical Oncology · 14
Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes
2017 · Elsa Curtit, Xavier Pivot, et al. · Breast Cancer Research · 10
PDF
Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients
2019 · Eric Voog, Boris Campillo‐Gimenez, et al. · International Journal of Cancer · 9
PDF
Prevention of 5-FU-induced health-threatening toxicity by pretherapeutic DPD deficiency screening: Medical and economic assessment of a multiparametric approach.
2013 · Michele Boisdron-Celle, Olivier Capitain, et al. · Journal of Clinical Oncology · 7
Geriatric Assessment Implementation before Chemotherapy in MEtastatic Prostate Cancer, Results from the Real-Life Study GAMERS
2023 · Cassandre Gluszak, Loïc Campion, et al. · Journal of Clinical Medicine · 6
PDF
Clinical benefits of non‐taxane chemotherapies in unselected patients with symptomatic metastatic castration‐resistant prostate cancer after docetaxel: the GETUG‐P02 study
2013 · Florence Joly, Remy Delva, et al. · British Journal of Urology · 6
Correlation of short telomeres (ST) with vulnerability, toxicity, and early death in elderly AOC patients receiving carboplatin: A multicenter GINECO trial.
2012 · Claire Falandry, Béatrice Horard, et al. · Journal of Clinical Oncology · 6
Predictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trial
2020 · for PRODIGE investigators/collaborators, Thomas Aparicio, et al. · British Journal of Cancer · 5
PDF
Non-pegylated liposomal doxorubicin (NPLD, Myocet®) + carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial
2018 · Clémence Romeo, Florence Joly, et al. · Gynecologic Oncology · 5
Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort
2017 · Xavier Pivot, Gilles Romieu, et al. · npj Breast Cancer · 5
PDF
Multidisciplinary analysis of cancer-related fatigue at the time of diagnosis: preliminary results of the BIOCARE FActory cohort
2024 · A. Leclercq, A. Chatrenet, et al. · Supportive Care in Cancer · 3
Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study
2023 · Caroline Gronnier, Christophe Mariette, et al. · Cancers · 3
PDF
Works count: 50
Citation count: 848
H-index: 14
I10-index: 15
Year
Topic
Type